GBIO Latest Quarter's Earnings
Announce Date 05/07/2025
EPS Normalized Actual $-0.22 (Beat by $0.03)
EPS GAAP Actual $-0.22 (Beat by $0.03)
Revenue Actual $0.004188B
Revenue Surprise Beat by $4.188M
Upcoming Quarter's Earnings
Announce Date 06/30/2025 (Pre-Market)
EPS Normalized Estimate $-0.2102
EPS GAAP Estimate $-0.2102
Revenue Estimate $0.00065B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Dec 2029 -0.14 -2.65 -0.37228 0.02670588 1
Dec 2028 -1.215 -0.31 -1.215 -1.215 2
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ4 2024 (Dec 2024) -0.23 0.04571 0.004188B 31.28% 2.44M
FQ3 2024 (Sep 2024) -0.23 -1.77141 0.007554B 71.59% 5.57M
FQ2 2024 (Jun 2024) -0.31 -0.31 0.004091B 78.49% 4.09M
FQ1 2024 (Mar 2024) -1.12 -1.12 0.004059B 100% 4.06M
FQ4 2023 (Dec 2023) -0.0006 -0.0006 0.002878B 100% 2.88M
FQ3 2023 (Sep 2023) -0.43 -0.43 0.002146B 100% 2.15M
FQ2 2023 (Jun 2023) -0.47 -0.47 0.00088B 100% 0.88M
FQ1 2023 (Mar 2023) -0.46 -0.46 0B NAN% 0M
Quarterly Estimates Summary

FQ4 Announce Date

06/30/2025 (Pre-Market)

Consensus EPS Estimates

-0.2102

Consensus Revenue Estimates

0.00065B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Oct 2026) -0.0991 -- -0.10806 -0.08971503 1
FQ3 2026 (Jul 2026) -0.0985 -- -0.1074 -0.08917185 1
FQ2 2026 (Jun 2026) -0.2445 -- -0.31785 -0.11369 3
FQ1 2026 (Mar 2026) -0.2442 -- -0.31746 -0.11355 3
FQ4 2025 (Oct 2025) -0.36 36.11 -0.39254 -0.32591 2
FQ3 2025 (Jul 2025) -0.35 34.29 -0.38164 -0.31685 2
FQ2 2025 (Jun 2025) -0.2102 -47.48 -0.2102 -0.2102 2
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Oct 2026) 0B -- 0B 0B 1
FQ3 2026 (Jul 2026) 0B -- 0B 0B 1
FQ2 2026 (Jun 2026) 0B -- 0B 0B 1
FQ1 2026 (Mar 2026) 0B -- 0B 0B 1
FQ4 2025 (Oct 2025) 0B -544.31 0B 0B 0
FQ3 2025 (Jul 2025) 0B -1062.15 0B 0B 0
FQ2 2025 (Jun 2025) 0B -529.38 0B 0B 0
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

1

EPS # of Misses

7

EPS # of in-lines

0

Revenue # of Beats

7

Revenue # of Misses

0

Revenue # of in-lines

1

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ4 2024 (Dec 2024) -0.27571 -0.23 0.04571 -19.87%
FQ3 2024 (Sep 2024) 1.54141 -0.23 -1.77141 770.18%
FQ2 2024 (Jun 2024) -0.31 -0.31 100%
FQ1 2024 (Mar 2024) -1.12 -1.12 100%
FQ4 2023 (Dec 2023) -0.0006 -0.0006 100%
FQ3 2023 (Sep 2023) -0.43 -0.43 100%
FQ2 2023 (Jun 2023) -0.47 -0.47 100%
FQ1 2023 (Mar 2023) -0.46 -0.46 100%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ4 2024 (Dec 2024) $0B $0B $2.44M 58.21%
FQ3 2024 (Sep 2024) $0B $0.01B $5.57M 73.79%
FQ2 2024 (Jun 2024) $0B $0B $4.09M 100%
FQ1 2024 (Mar 2024) $0B $0B $4.06M 100%
FQ4 2023 (Dec 2023) $0B $0B $2.88M 100%
FQ3 2023 (Sep 2023) $0B $0B $2.15M 100%
FQ2 2023 (Jun 2023) $0B $0B $0.88M 100%
FQ1 2023 (Mar 2023) $0B $0B $0M NAN%
Unlock